Alex Kim
Direttore/Membro del Consiglio presso Co-D Therapeutics, Inc.
Posizioni attive di Alex Kim
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Co-D Therapeutics, Inc.
 Co-D Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Co-D Therapeutics, Inc. operates as a preclinical stage biopharmaceutical firm. Its product, Triolimus, helps treats cancer. The company was founded by Kevin R. Kozak, Glen S. Kwon, and Abdalla A. Saad and is headquartered in Madison, WI. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Alex Kim
Precedenti posizioni note di Alex Kim
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Direttore/Membro del Consiglio | 01/05/2007 | 20/07/2021 |
| Amministratore Delegato | 01/01/2019 | 20/07/2021 | |
| Presidente | 20/07/2021 | 26/10/2021 | |
Immunomic Therapeutics, Inc.
 Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Direttore/Membro del Consiglio | 05/05/2020 | - |
| HLB CO., LTD. | Direttore/Membro del Consiglio | - | - |
Formazione di Alex Kim
| Sophia University | Graduate Degree |
| University of Utah | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Corea del Sud | 2 |
| Giappone | 2 |
Posizioni
| Director/Board Member | 4 |
| Graduate Degree | 1 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HLB CO., LTD. | Health Technology |
| Aziende private | 3 |
|---|---|
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Health Technology |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
Co-D Therapeutics, Inc.
Co-D Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Co-D Therapeutics, Inc. operates as a preclinical stage biopharmaceutical firm. Its product, Triolimus, helps treats cancer. The company was founded by Kevin R. Kozak, Glen S. Kwon, and Abdalla A. Saad and is headquartered in Madison, WI. | Commercial Services |
- Borsa valori
- Insiders
- Alex Kim
- Esperienza
